Hochschulschrift
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
VII, 93 Blätter
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Ruprecht-Karls-Universität, Dissertation, 2016
- Classification
-
Medizin, Gesundheit
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 12:09 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- 2015
Other Objects (12)
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
MicroRNA-sensitive oncolytic measles virus vectors for chemovirotherapy of pancreatic cancer
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Exploring the Interplay of Oncolytic Measles Vaccines with the Cancer-Immunity Cycle
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
MicroRNA-sensitive oncolytic measles virus vectors for chemovirotherapy of pancreatic cancer
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Exploring the Interplay of Oncolytic Measles Vaccines with the Cancer-Immunity Cycle
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
MicroRNA-sensitive oncolytic measles virus vectors for chemovirotherapy of pancreatic cancer
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Exploring the Interplay of Oncolytic Measles Vaccines with the Cancer-Immunity Cycle